Last but not least, liraglutide/GLP-1 RA may have beneficial effects on gut microbiota, preventing microbiome dysbiosis and endotoxemia, thus leading to a less severe form of coronavirus disease [48]. The gene discussed is GCG; the disease is serum lipopolysaccharide activity.